Arch Biopartners Inc. (ACHFF)
OTC
Closed
Aug 26, 2026
Day's Range
0.726052 wk Range
0.2880Overview - ACHFF - Arch Biopartners Inc.
Key Statistics
Valuation
Enterprise Value
42.13M
P/E (Trailing)
‪-30.25‬
P/E (Forward)
‪-10.51‬
PEG Ratio
‪1.36‬
Price / Sales (TTM)
‪316.16‬
Price / Book
‪-13.33‬
EV / EBITDA
‪-33.93‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-1,418.63%‬
Return on Assets
‪-276.77%‬
Return on Equity
‪40.00%‬
Ownership
Shares Outstanding
67.72M
Float
53.52M
Held by Insiders
‪18.29%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.72‬
50-Day Avg
‪0.6197‬
200-Day Avg
‪0.6064‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - ACHFF - Arch Biopartners Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - ACHFF - Arch Biopartners Inc.
About
Arch Biopartners Inc. is a biotechnology company that focuses on developing innovative medical treatments for addressing complex and unmet medical needs. The company's primary function is to conduct research and development in the field of clinical therapeutics, with a special focus on organ disease and injury. Arch…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
